Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Plos One|November 24, 2011
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in EuropeEsther Kissling, Marta Valenciano, Jean Marie Cohen, et al.
Influenza and Other Respiratory Viruses|March 20, 2023
Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case-case study based on electronic health recordsIrina Kislaya, André Peralta-Santos, Vítor Borges, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 11, 2025
Surveillance of severe acute respiratory infections associated with SARS-CoV-2, influenza virus and RSV using ICD-10 codes: a case definition accuracy study across five European countries, 2021 to 2023Miguel Angel Sanchez Ruiz, Diogo Fp Marques, Frederikke Kristensen Lomholt, et al.
Vaccine|February 3, 2022
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysisFrank G Sandmann, Edwin van Leeuwen, Sibylle Bernard-Stoecklin, et al.
Plos One|March 9, 2026
Modelling approaches for estimating vaccine effectiveness of consecutive SARS-CoV-2 variant sublineages in the absence of study-specific genetic sequencing data, VEBIS hospital network, Europe, 2023/24Liliana Antunes, Baltazar Nunes, Olivier Núñez, et al.
Emerging Infectious Diseases|February 3, 2023
Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, PortugalIrina Kislaya, Pedro Casaca, Vítor Borges, et al.
Influenza and Other Respiratory Viruses|April 17, 2018
Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017Marta Valenciano, Esther Kissling, Amparo Larrauri, et al.
International Journal of Epidemiology|June 19, 2025
The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general populationCharlotte Lanièce Delaunay, Baltazar Nunes, Susana Monge, et al.
Influenza and Other Respiratory Viruses|May 27, 2024
Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross-Sectional Study From 2014 to 2019Raquel Guiomar, Susana Pereira da Silva, Inês Costa, et al.
The Lancet. Planetary Health|August 9, 2023
Global short-term mortality risk and burden associated with tropical cyclones from 1980 to 2019: a multi-country time-series studyWenzhong Huang, Shanshan Li, Thomas Vogt, et al.
Pageof 16